We have tracked over 2 funding programs and $1,500,000 allocated for HIV and AIDS support.
| Recent Funding Opportunity |
|---|
| AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) (Apply for PAR 18 832) Funding Number: PAR 18 832 Agency: National Institutes of Health Funding Amount: $1,500,000 |
| Enhancing Comprehensive Community-Based and Sustainable HIV/AIDS Key Population (KP) Prevention Services and Treatment Support for KP Living with HIV in the Republic of Zambia under PEPFAR (Apply for CDC RFA GH 23 0011) Funding Number: CDC RFA GH 23 0011 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Funding Amount: Case Dependent |
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More